Literature DB >> 32725309

Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing : Overall analysis of a female with POR deficiency.

Tao Zhang1, Zhou Li1, Xinling Ren1, Bo Huang1, Guijin Zhu1, Wei Yang2, Lei Jin3.   

Abstract

OBJECTIVE: To characterize the clinical features of a female with P450 oxidoreductase (POR) deficiency and to investigate the underlying mechanisms of POR inactivation.
METHODS: The proband was a 35-year-old woman with primary infertility and menstrual irregularity. The reproductive endocrine profile was evaluated. DNA sequencing was conducted for the identification of POR gene mutation. RT-PCR was performed to confirm the impact of the mutation on POR mRNA. A molecular model was built for the structural analysis of mutant POR protein.
RESULTS: The evaluation of reproductive endocrine profile revealed elevation of serum follicle-stimulating hormone (11.48 mIU/ml), progesterone (11.00 ng/ml), 17α-hydroxyprogesterone (24.24 nmol/l), dehydroepiandrosterone (6300 nmol/l), and androstenedione (3.89 nmol/l) and decreased estradiol (36.02 pg/ml). Sequencing of the POR gene showed the female was a compound heterozygote of the paternal P399_E401 deletion and a novel maternal IVS14-1G>C mutation. Functional analysis revealed IVS14-1G>C mutation caused alternative splicing of POR mRNA, with the loss of 12 nucleotides in exon 15 (c.1898_1909delGTCTACGTCCAG). Also, the resulting mutant POR protein had a V603_Q606 deletion, which inactivated the nucleotide-binding domain of NADPH in POR protein (K602_Q606).
CONCLUSION: The mutation IVS14-1G>C of the POR gene could cause alternative splicing of POR mRNA and dysfunction of the resulting POR protein. Under proper IVF strategy with glucocorticoid therapy and endometrial preparation, females with mild POR deficiency still have the opportunity to have a live birth.

Entities:  

Keywords:  Alternative splicing; Compound heterozygote; Cytochrome P450 oxidoreductase deficiency; In vitro fertilization; Live birth

Mesh:

Substances:

Year:  2020        PMID: 32725309      PMCID: PMC7550433          DOI: 10.1007/s10815-020-01899-z

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  41 in total

Review 1.  Minireview: regulation of steroidogenesis by electron transfer.

Authors:  Walter L Miller
Journal:  Endocrinology       Date:  2005-03-17       Impact factor: 4.736

2.  Expression and characterization of truncated human heme oxygenase (hHO-1) and a fusion protein of hHO-1 with human cytochrome P450 reductase.

Authors:  A Wilks; S M Black; W L Miller; P R Ortiz de Montellano
Journal:  Biochemistry       Date:  1995-04-04       Impact factor: 3.162

3.  Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis.

Authors:  Diana M E Otto; Colin J Henderson; Dianne Carrie; Megan Davey; Thomas E Gundersen; Rune Blomhoff; Ralf H Adams; Cheryll Tickle; C Roland Wolf
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

4.  Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome.

Authors:  Christa E Flück; Toshihro Tajima; Amit V Pandey; Wiebke Arlt; Kouji Okuhara; Charles F Verge; Ethylin Wang Jabs; Berenice B Mendonça; Kenji Fujieda; Walter L Miller
Journal:  Nat Genet       Date:  2004-02-01       Impact factor: 38.330

5.  In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report.

Authors:  Tianran Song; Bin Wang; Huan Chen; Jingjing Zhu; Haixiang Sun
Journal:  Gynecol Endocrinol       Date:  2017-10-26       Impact factor: 2.260

Review 6.  Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.

Authors:  Christa E Flück; Catherine Nicolo; Amit V Pandey
Journal:  Fundam Clin Pharmacol       Date:  2007-08       Impact factor: 2.748

7.  In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate.

Authors:  Michael T Zavy; LaTasha B Craig; Robert A Wild; Sana N Kahn; Dena O'Leary; Karl R Hansen
Journal:  Reprod Biol Endocrinol       Date:  2014-11-28       Impact factor: 5.211

8.  Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations.

Authors:  Georgios E Papadakis; Agathe Dumont; Jerome Bouligand; Fanny Chasseloup; Anna Raggi; Sophie Catteau-Jonard; Odile Boute-Benejean; Nelly Pitteloud; Jacques Young; Didier Dewailly
Journal:  Hum Reprod       Date:  2020-04-28       Impact factor: 6.918

9.  Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study.

Authors:  Wiebke Arlt; Elizabeth A Walker; Nicole Draper; Hannah E Ivison; Jon P Ride; Fabian Hammer; Susan M Chalder; Maria Borucka-Mankiewicz; Berthold P Hauffa; Ewa M Malunowicz; Paul M Stewart; Cedric H L Shackleton
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

10.  Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.

Authors:  Yan Huang; En-Yin Wang; Qing-Yun Du; Yu-Jing Xiong; Xiao-Yi Guo; Yi-Ping Yu; Ying-Pu Sun
Journal:  Reprod Biol Endocrinol       Date:  2015-08-04       Impact factor: 5.211

View more
  4 in total

Review 1.  Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature.

Authors:  C Gusmano; R Cannarella; A Crafa; F Barbagallo; S La Vignera; R A Condorelli; A E Calogero
Journal:  J Endocrinol Invest       Date:  2022-07-17       Impact factor: 5.467

2.  Antley-Bixler syndrome arising from compound heterozygotes in the P450 oxidoreductase gene: a case report.

Authors:  Haibo Li; Aman Zhao; Min Xie; Linqi Chen; Haiying Wu; Yiping Shen; Hongying Wang
Journal:  Transl Pediatr       Date:  2021-12

3.  In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.

Authors:  Muhammad Nurhafizuddin; Aziemah Azizi; Long Chiau Ming; Naeem Shafqat
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

4.  Getting pregnant with congenital adrenal hyperplasia: Assisted reproduction and pregnancy complications. A systematic review and meta-analysis.

Authors:  Xiaoyan Guo; Yu Zhang; Yiqi Yu; Ling Zhang; Kamran Ullah; Mengxia Ji; Bihui Jin; Jing Shu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.